Inovio Pharmaceuticals (INO) Goodwill & Intangibles (2010 - 2023)

Inovio Pharmaceuticals has reported Goodwill & Intangibles for 14 years, with the latest figure at $10.5 million in Q2 2023.

• Quarterly Goodwill & Intangibles fell 18.39% year-over-year to $10.5 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $10.5 million (down 18.39% YoY) and the FY2022 annual result came in at $12.6 million, down 3.78% from the prior year.
• Goodwill & Intangibles fell to $10.5 million in Q2 2023 per INO's latest filing, from $12.6 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $15.0 million in Q1 2019 and troughed at $10.5 million in Q2 2023.
• A 5-year average of $13.4 million and a median of $13.5 million in 2021 frame the typical range for Goodwill & Intangibles.
• The widest YoY moves for Goodwill & Intangibles: up 3.47% in 2023, down 18.39% in 2023.
• Over 5 years, Goodwill & Intangibles stood at $14.2 million in 2019, then fell by 3.85% to $13.7 million in 2020, then fell by 3.81% to $13.1 million in 2021, then slipped by 3.78% to $12.6 million in 2022, then fell by 16.85% to $10.5 million in 2023.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $10.5 million, $12.6 million, and $12.6 million for Q2 2023, Q1 2023, and Q4 2022 respectively.